Trial clarifies risks of low-dose methotrexate

However, absolute risk is low, say researchers

Low-dose methotrexate can be associated with ‘small to moderate’ elevations in risk for skin cancer and pulmonary, gastrointestinal, haematological and infectious adverse effects (AE), US researchers say.